Abstract
A placebo-controlled dose-response study of the direct serotonin receptor agonistm-chlorophenylpiperazine (MCPP), intravenously infused over 90 s in 0.06 and 0.08 mg/kg doses, was conducted in nine normal male subjects. Cortisol, prolactin, MCPP serum levels and behavioral responses were measured over a 210-min period. Both doses caused significant cortisol and prolactin release and were associated with significantly greater behavioral effects as compared to placebo. Though the two doses were associated with different MCPP serum levels, they did not significantly differ in their hormonal and behavioral effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989) Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125:2664–2669
Charney DS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 92:14–24
Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR (1988) Serotonin function in obsessive-compulsive disorder: a comparison of the effects of tryptophan andm-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 45:177–185
Endicott F, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837–844
Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR (1988) Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. Am J Psychiatry 145:1015–1017
Kahn RS, Asnis GM, Wetzler S, van Praag HM (1988) Neuroendocrine evidence for serotonin receptor hypersensitivity in patients with panic disorder. Psychopharmacology 96:360–364
Kahn RS, Wetzler S, Asnis GM, van Praag HM (1990a) The effects ofm-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology 100:339–344
Kahn RS, Kalus O, Wetzler S, Cahn W, Asnis GM, van Praag HM (1990b) The effects of serotonin antagonists onm-chlorophenylpiperazine-mediated responses in normal subjects. Psychiatry Res 33:189–198
Kahn RS, Wetzler S, Asnis GM, Papolos D, van Praag HM (1990c) Serotonin receptor sensitivity in major depression. Biol Psychiatry 28:358–362
Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL (1989) Hyperresponsivity to the serotonin agonistm-chlorophenylpiperazine in Alzheimer's disease. Arch Gen Psychiatry 46:542–549
Mueller EA, Sunderland T, Murphy DL (1985) Neuroendocrine effects ofm-CPP, a serotonin agonist, in humans. J Clin Endocrinol Metab 61:1179–1184
Mueller EA, Murphy DL, Sunderland T (1986) Further studies of the putative serotonin agonist,m-chlorophenylpiperazine evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89:388–391
Murphy DL, Mueller EA, Hill JL, Tolliver TJ, Jacobson FM (1989) Comparative anxiogenic, neuroendocrine, and other physiologic effects ofm-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology 98:275–282
Spitzer RL, Endicott J, Robins E (1978) Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 35:773–782
Suckow RF, Cooper TB, Kahn RS (1990) High-performance liquid chromatographic method for analysis of plasmam-chlorophenylpiperazine. J Chromatogr 528:228–234
Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 44:946–951
Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL (1988) Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment. Arch Gen Psychiatry 45:167–172
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalus, O., Wetzler, S., Kahn, R.S. et al. A dose-response study of intravenousm-chlorophenylpiperazine in normal subjects. Psychopharmacology 106, 388–390 (1992). https://doi.org/10.1007/BF02245423
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245423